GSK confirms probe by Chinese authoritiesBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4328 (Published 03 July 2013) Cite this as: BMJ 2013;347:f4328
- Jane Parry
- 1Hong Kong
A group of senior executives at GlaxoSmithKline is at the centre of an investigation by Chinese authorities into the company’s operations in China.
Managers from each of the UK based drug firm’s three sites in Beijing, Changsha, and Shanghai are believed to be in police custody, report the official news agency Xinhua and the Hong Kong newspaper South China Morning Post.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial